Tamsulosin is the most potent adrenergic alpha-1 antagonist used for the treatment of benign prostatic hyperplasia. Priapism has been reported rarely in patients taking Prazosin, Doxazosin and Terazosin. We describe an otherwise healthy man with recurrent and then persistent unresolved priapism after the use of tamsulosin. Initial treatment consisted of aspiration and intracavernosal irrigation of iced saline and vasoconstrictive agent, but in vain. We then performed Winters procedure but that too failed and the priapism persisted. Health-care professionals should inform all patients taking such medications about rare but possible serious adverse effects.
Case report
A 56-year-old man presented with painful erection 26-28 h in duration. He had been taking tamsulosin 0.4 mg daily for about 2 weeks for benign prostatic hyperplasia (BPH). He gave history of painful erections every time he took the medication, each lasting for about 3-5 h. He gave no history of trauma or sexual activity, ingestion of alcohol or any other drug. Dark blood was aspirated from the corpora followed by irrigation with saline and then 250-500 mm of saline-diluted phenylephrine solution every 3-5 min. Both these treatments were unsuccessful. Blood gases were performed from the aspirated corporal blood in the emergency department, which suggested a low flow type of priapism. An urgent colour Doppler was then undertaken, which demonstrated sluggish flow within the corpora again suggestive of a low flow (venoocclusive) type of priapism. A distal transglandular cavernosal shunt was then performed, but this too was unsuccessful and the priapism persisted in the postoperative period.
Discussion
It has been observed that increased duration of priapism is associated with a worse prognosis. The mechanism responsible for priapism is an alpha adrenergic blockade, which directly inhibits the sympathetic impulse of detumescence.
1,2 Tamsulosin is a subtype selective alpha-blocker with effect on prostate, but it appears it may also have an effect on the corporal smooth muscle. Tamsulosin is the only alpha-blocker for which it has been shown that it can significantly improve overall sexual function in a placebo-controlled study. 3 Hence, the observed priapism could be interpreted as the extreme end of a spectrum of manifestations of an otherwise desired phenomenon. There is some anecdotal evidence that priapism may be precipitated when taking high doses of tamsulosin or concomitant drugs that inhibit its metabolism. In patients with intractable recurrent priapism, oral alpha adrenergic agents have been suggested with variable results. Patients with prolonged or repetitive episodes of priapism are highly likely to suffer erectile dysfunction after resolution of the condition (secondary to fibrosis). As this condition can lead to permanent impotence if not timely treated, patients must be advised about the seriousness of the condition. To our knowledge, only one detailed case of resolved priapism following tamsulosin has ever been reported before. 4 We report this case of recurrent and then unresolved priapism following ingestion of tamsulosin (0.4 mg) that failed to respond to any treatment. Given the widespread use of this drug and the emerging newer medications for BPH, it would not be surprising to see more such cases in the future. Patients should not only be alerted about the possibility of this complication but also that upon initial observations of painful involuntary erections following use of an alpha-blocker, this type of medication should be stopped and not resumed.
